Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica

Veterinary Therapeutics

Volumn 8, Issue 1, 2007, Pages 32-40

  Davis, Randy ^a   Jayappa, Huchappa ^a   Abdelmagid, Omar Y ^a   Armstrong, Rob ^a   Sweeney, Diane ^a   Lehr, Craig ^a  

^a MERCK ANIMAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORDETELLA BRONCHISEPTICA; CANIS FAMILIARIS;

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A;

ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; BLOOD; BORDETELLA BRONCHISEPTICA; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; NOSE MUCOSA; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; BRONCHITIS; DOG DISEASES; DOGS; IMMUNOGLOBULIN A; INJECTIONS, SUBCUTANEOUS; NASAL MUCOSA; TREATMENT OUTCOME; VACCINATION;

EID: 34249736937     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bemis DA: Bordetella and Mycoplasma respiratory infections in dogs and cats. Vet Clin North Am Small Anim Pract 22(5):1173-1186, 1992.
2. Datz C: Bordetella infections in dogs and cats: Pathogenesis, clinical signs and diagnosis. Compend Contin Educ Pract Vet 25(12):896-901, 2003
3. Datz C: Bordetella infections in dogs and cats: Treatment and prevention. Compend Contin Educ Pract Vet 25(12):902-914, 2003.
4. Bemis DA, Greisen HA, Appel MJG: Pathogenesis of canine bordetellosis. J Infect Dis 135(5):753-762, 1977.
5. Bey RF, Shade FJ, Goodnow RA, Johnson RC: Intranasal vaccination of dogs with live avirulent Bordetella bronchiseptica: Correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis. Am J Vet Res 42:1130-1132, 1981.
6. Kontor EJ, Wegrzyn MA, Goodnow RA: Canine infectious tracheobronchitis: Effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough). Am J Vet Res 42:1694-1698, 1981.
7. Ellis JA, Haines DM, West KH, et al: Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. JAVMA 218(3):367-375, 2001.
8. Ellis JA, Krakowka GS, Dayton AD, Konoby C: Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs. JAVMA 220(1):43-48, 2002.
9. German AJ, Hall EJ, Day MJ: Measurement of IgG, IgM and IgA concentrations in canine serum, saliva, tears and bile. Vet Immunol Immunopathol 64:107-121, 1998.
10. Tizard IR: Veterinary Immunology: An Introduction. Philadelphia, WB Saunders, 1996, p 256.
11. Tizard IR: Veterinary Immunology: An Introduction. Philadelphia, WB Saunders, 1996, p 262.
12. Tomoda T, Morita H, Kurashige T, Maassab HF: Prevention of influenza by the intranasal administration of cold- recombinant, live-attenuated influenza virus vaccine: Importance of interferon-γ production and local IgA response. Vaccine 13(2):185-190, 1995.
13. Janeway CA, Travers P, Walport M, Capra JD: Immunobiology: The Immune System in Health and Disease, ed 4. London, Garland Publishing, 1999, pp 326-327.
14. Cárdenas-Freytag L, Cheng E, Mirza A: New approaches to mucosal immunization, in Paul PS, Francis DH (eds): Mechanisms in the Pathogenesis of Enteric Diseases 2. New York, Kluwer Academic/Plenum Publishers, 1999, pp 319-337.
15. Quiding-Järbrink M, Nordström I, Granström G, et al: Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. J Clin Invest 99(6):1281-1286, 1997.